SBIR

Valid Eval Helps Department of Transportation Manage $5 Billion Program with Evaluation Services

Retrieved on: 
Wednesday, October 5, 2022

The program supports Secretary of Transportation Pete Buttigieg's National Roadway Safety Strategy and the Department's goal of zero deaths and serious injuries on our nation's roadways.

Key Points: 
  • The program supports Secretary of Transportation Pete Buttigieg's National Roadway Safety Strategy and the Department's goal of zero deaths and serious injuries on our nation's roadways.
  • Valid Eval was also awarded a contract to facilitate the evaluation of grants submitted to the Strengthening Mobility and Revolutionizing Transportation (SMART) discretionary grant program with $100 million appropriated annually for FY22-26.
  • The Valid Eval assessment and feedback tool was first utilized at DoT in the Spring of 2020 to help manage the Department's SBIR program and was recently awarded a purchase order to implement large-scale evaluation services for the Department of Transportation (DoT) University Transportation Centers (UTCs).
  • To date, Valid Eval has supported over 120 U.S. Federal government programs to screen industry submissions and improve tech evaluations.

SIMBA Chain awarded SpaceWERX Orbital Prime Contract

Retrieved on: 
Wednesday, October 5, 2022

Orbital Prime was created to accelerate the commercial ISAM market toward a use case of Active Debris Remediation.

Key Points: 
  • Orbital Prime was created to accelerate the commercial ISAM market toward a use case of Active Debris Remediation.
  • SIMBA Chain (short for Simple Blockchain Applications) has simplified blockchain app development by removing complexities involved and making the technology accessible by all developers, regardless of their blockchain know-how.
  • SpaceWERX Orbital Prime leverages a diverse industry partnership engagement strategy to identify nascent space technology sectors that, if primed, could advance U.S. national security and economic prosperity.
  • The first Space Prime effort, Orbital Prime will invigorate the In-space Servicing, Assembly, and Manufacturing (ISAM) market using Active Debris Remediation (ADR) as a use case for the foundational technologies.

Alex Lindblad, 20-Year Technology Expert, Joins DrivenIQ as Chief Technology Officer and Business Advisor

Retrieved on: 
Tuesday, October 4, 2022

TOWSON, Md. , Oct. 4, 2022  /PRNewswire-PRWeb/ -- DrivenIQ, the authority in audience data and advertising technologies, today announced that 20-year technology expert, Alex Lindblad, has joined the company as Chief Technology Officer and Business Advisor. Currently he serves as a technical and business advisor at Trupropel, a full service software development company specializing in both the automotive industry and large-scale data products. As CTO of DrivenIQ, Alex will lead the technology team to streamline its rapidly growing development operations. In addition to overseeing the technology department, Alex will bring his experience and guidance in creating operational processes to support corporate alignment and goal setting to accelerate business growth.

Key Points: 
  • TOWSON, Md., Oct. 4, 2022 /PRNewswire-PRWeb/ -- DrivenIQ , the authority in audience data and advertising technologies, today announced that 20-year technology expert, Alex Lindblad, has joined the company as Chief Technology Officer and Business Advisor.
  • As CTO of DrivenIQ, Alex will lead the technology team to streamline its rapidly growing development operations.
  • In addition to overseeing the technology department, Alex will bring his experience and guidance in creating operational processes to support corporate alignment and goal setting to accelerate business growth.
  • Alex has a long and storied career in technology, beginning in 2000 at the University of Minnesota.

Xosomix Awarded NIH Phase I SBIR Grant to Develop Diagnostic Biomarker for Endometriosis

Retrieved on: 
Tuesday, October 4, 2022

This grant will enable Xosomix to develop an early diagnostic biomarker for endometriosis.

Key Points: 
  • This grant will enable Xosomix to develop an early diagnostic biomarker for endometriosis.
  • Xosomix receives SBIR from NICHD to develop non-invasive biomarker that avoids surgery, the only FDA approved diagnosis
    Approximately 10% of reproductive age women, more than 4 million in United States alone, are affected by endometriosis.
  • This is an underestimate as invasive surgery is the only FDA approved diagnosis of endometriosis.
  • Xosomix has a proprietary platform technology that can tap into all the signals in exosomes on an individual basis at discovery phase.

AmideBio Awarded SBIR Phase IIB Grant to Support Pre-Clinical Development of its Long-Acting Stable Glucagon Analog for the Treatment of Hyperinsulinism

Retrieved on: 
Tuesday, October 4, 2022

This two-year grant will allow AmideBio to select a long-acting soluble stable glucagon candidate and do the necessary work to support the filing of an Investigational New Drug (IND) application with the FDA at the end of the grant period.

Key Points: 
  • This two-year grant will allow AmideBio to select a long-acting soluble stable glucagon candidate and do the necessary work to support the filing of an Investigational New Drug (IND) application with the FDA at the end of the grant period.
  • In addition, the Company will file for both orphan drug and rare pediatric disease designation with the FDA.
  • Congenital hyperinsulinism is a rare disease that affects newborns and results in persistent hypoglycemia which can lead to serious neurological complications including seizures and brain damage.
  • "We are honored to receive this Phase IIB SBIR grant from the NIH.

Livivos, Inc. Announces Award of NIH Grant for Its LiverScope® Device

Retrieved on: 
Tuesday, October 4, 2022

Currently, fatty liver disease can be diagnosed with MRI scanners, but these are expensive, bulky, require dedicated shielded rooms and trained technicians, and can induce claustrophobia in patients.

Key Points: 
  • Currently, fatty liver disease can be diagnosed with MRI scanners, but these are expensive, bulky, require dedicated shielded rooms and trained technicians, and can induce claustrophobia in patients.
  • "We are excited to be working with the NIDDK and our UC San Diego collaborators, who are the country's leading experts on liver imaging."
  • Livivos is introducing its LiverScope, an innovative, Point-of-Care liver disease diagnostic device that has the potential to revolutionize how the disorder is detected, graded, and managed.
  • Dr. Claude Sirlin of UCSD serves as an advisor to Livivos, Inc. and holds stock in the company.

Sure Med Compliance Raises $1 Million Pre-Series A to Tackle the Overdose Epidemic

Retrieved on: 
Monday, October 3, 2022

MOBILE, Ala., Oct. 3, 2022 /PRNewswire/ -- Sure Med Compliance, an early-stage digital health startup focused on curbing the opioid-related overdose epidemic has raised $1 Million to help fund a national launch of their novel platform, Perspectives in CareSM.

Key Points: 
  • MOBILE, Ala., Oct. 3, 2022 /PRNewswire/ -- Sure Med Compliance, an early-stage digital health startup focused on curbing the opioid-related overdose epidemic has raised $1 Million to help fund a national launch of their novel platform, Perspectives in CareSM.
  • In May of this year, Sure Med Compliance Began a soft launch of their opioid therapy focused platform into several prolific pain groups across the US.
  • Speaking on the latest funding, John Bowman, Founder, and CEO of Sure Med Compliance, said, "At Sure Med Compliance we believe that mitigating risk to the provider is the most effective way to improve patient outcomes in pain management settings.
  • Based in Mobile Alabama, Sure Med Compliance is a healthcare technology company, dedicated to creating safer exposures to controlled substances.

SBA Awards Over $5.4 Million in Grants to Strengthen Research Funding Opportunities Across the U.S.

Retrieved on: 
Friday, September 30, 2022

FAST provides small businesses and startups, particularly those in underserved communities, with specialized training, mentoring, and technical assistance for research and development.

Key Points: 
  • FAST provides small businesses and startups, particularly those in underserved communities, with specialized training, mentoring, and technical assistance for research and development.
  • This years expansion of the FAST program created 12 additional awards and expands the programs footprint to 43 states and one U.S. territory.
  • With $4 million in funding in fiscal year 2021, FAST helped small businesses to win over $88 million in SBIR and STTR awards, a 22:1 return for every taxpayer dollar spent.
  • The FAST program provides awards for a base period of 12 months, plus four optional continuation periods of 12 months each.

Eviscerating Pathogenic Microbes While Harmless to Human Skin and Epithelial Eye Cells Granted US Patent

Retrieved on: 
Friday, September 30, 2022

Delicate eyes endure the onslaught of a world of microbes that move unabated and virtually weightless throughout all environments.

Key Points: 
  • Delicate eyes endure the onslaught of a world of microbes that move unabated and virtually weightless throughout all environments.
  • Physical contact with the eye from simple touching and rubbing, to placing contacts represent only a fraction of the ways pathogens infest sensitive organs.
  • The dichotomy of a preservative-free eye solution in an environment contaminated with incomprehensible numbers of harmful pathogens is problematic and limiting.
  • In a world where, "first, do no harm" is sacrosanct, the preponderance of eye solutions contain caustic preservatives that damage epithelial cells.

Administrator Guzman Applauds Passage of Small Business Innovation Research (SBIR) Program Reauthorization, Committing to Scientific and Technology Innovation

Retrieved on: 
Friday, September 30, 2022

Washington, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Administrator Isabella Casillas Guzman , head of the U.S. Small Business Administration and voice for Americas 33 million small businesses in President Bidens Cabinet, released the following statement today after the House voted to reauthorize funding for the Small Business Innovation Research (SBIR) program:

Key Points: 
  • Washington, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Administrator Isabella Casillas Guzman , head of the U.S. Small Business Administration and voice for Americas 33 million small businesses in President Bidens Cabinet, released the following statement today after the House voted to reauthorize funding for the Small Business Innovation Research (SBIR) program:
    Todays Congressional vote demonstrates strong bipartisan support for the Small Business Innovation Research program, which is vital to our nations capacity to innovate and improve the lives of all Americans.
  • A new three-year reauthorization for SBIR is a significant win for our nations small businesses and the American jobs it supports.
  • The U.S. Small Business Administration helps power the American dream of business ownership.
  • It delivers services through an extensive network of SBA field offices and partnerships with public and private organizations.